Bioactive Lipid Mediators in Cardiopulmonary Pharmacology: Unlocking Novel Therapeutics

Edited by Darryl C Zeldin and John Seubert, Bioactive Lipid Mediators in Cardiopulmonary Pharmacology, Volume 97 is a comprehensive update on the role of bioactive lipid mediators in regulating physiological and pathophysiological responses. These mediators are intricately involved in a vast array of signaling pathways, making them a crucial area of research.

Expert Insights into Bioactive Lipid Mediators

This volume features expert reviews from world-renowned authorities in the field, covering a range of topics including:

• Cyclooxygenases and Vascular Function
• Cyclooxygenases and Platelet Function
• Eicosanoids and Cardiomyopathies
• Cytochrome P450 Bioactive Lipids in the Heart
• Epoxide Hydrolase and Leukotoxin in the Heart and Lung
• Role of cytochrome P450-epoxygenase and soluble epoxide hydrolase in the regulation of vascular response
• Bioactive Lipids in Hypertension
• Cytochrome P450 Metabolites and Angiogenesis
• 20-Hydroxyeicosatetraenoic Acid and Vascular Function

Delving into the Complexity of Bioactive Lipids

Additional critical sections explore the intricacies of bioactive lipids, including:

• Cytochrome P450 Eicosanoids and the Brain
• Omega-3 Oxylipids
• Resolvins, Lipoxins, and Inflammation
• Endocannabinoids as Bioactive Metabolites
• Oxylipins and Aspirin Exacerbated Respiratory Disease

This comprehensive volume provides a cutting-edge understanding of bioactive lipid mediators, emphasizing the development of novel therapeutics. The diverse range of bioactive lipids derived from COX, LOX, or CYP-mediated metabolism of omega-3 and omega-6 PUFAs is extensively covered, making it an invaluable resource for researchers and clinicians alike.

Publication Details:

publisher: Academic Press

Edition: 1st edition

Release Date: June 8, 2023

Language: English

Format: Hardcover

Pages: 462

ISBN-10: 0323950574

ISBN-13: 978-0323950572